ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

CUSIP: 682310875

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, no par value
Shares outstanding
109,272,143
Total 13F shares
6,216,229
Share change
+5,450,042
Total reported value
$13,562,379
Price per share
$2.18
Number of holders
32
Value change
+$11,870,396
Number of buys
16
Number of sells
9

Security key

682310875

Report period

Q3 2023

Institutions

32

Top holders

10

Top shareholders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
13F
Company
0.18%
194,963
$506,904 30 Jun 2023
13F
MORGAN STANLEY
13F
Company
0.17%
184,213
$478,954 30 Jun 2023
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.06%
68,320
$177,632 30 Jun 2023
13F
CIBC WORLD MARKET INC.
13F
Company
0.06%
60,913
$161,000 30 Jun 2023
13F
ROYAL BANK OF CANADA
13F
Company
0.05%
53,205
$138,000 30 Jun 2023
13F
Long Focus Capital Management, LLC
13F
Company
0.04%
40,000
$104,000 30 Jun 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.03%
34,659
$90,113 30 Jun 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.03%
33,485
$87,061 30 Jun 2023
13F
BANK OF MONTREAL /CAN/
13F
Company
0.03%
32,380
$85,291 30 Jun 2023
13F
Newman Dignan & Sheerar, Inc.
13F
Company
0.02%
18,915
$49,179 30 Jun 2023
13F
UBS Group AG
13F
Company
0.01%
13,454
$34,980 30 Jun 2023
13F
OSAIC HOLDINGS, INC.
13F
Company
0.01%
12,386
$32,789 30 Jun 2023
13F
Cantonale Vaudoise Banque
13F
Individual
0.01%
11,900
$31,000 30 Jun 2023
13F
HEADINVEST, LLC
13F
Company
0.01%
11,534
$23,414 30 Jun 2023
13F
BRAVE ASSET MANAGEMENT INC
13F
Company
0.01%
10,000
$26,377 30 Jun 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
6,201
$16,121 30 Jun 2023
13F
Cedar Mountain Advisors, LLC
13F
Company
0.01%
5,651
$14,693 30 Jun 2023
13F
Disciplined Investments, LLC
13F
Company
0%
5,189
$13,491 30 Jun 2023
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0%
4,770
$12,241 30 Jun 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
4,642
$12,070 30 Jun 2023
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
2,639
$6,861 30 Jun 2023
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0%
2,539
$6,521 30 Jun 2023
13F
TD Waterhouse Canada Inc.
13F
Company
0%
557
$1,894 30 Jun 2023
13F
Clearview Wealth Advisors LLC
13F
Company
0%
500
$1,300 30 Jun 2023
13F
NewSquare Capital LLC
13F
Company
0%
220
$572 30 Jun 2023
13F
JNBA Financial Advisors
13F
Company
0%
210
$546 30 Jun 2023
13F
First Capital Advisors Group, LLC.
13F
Company
0%
200
$520 30 Jun 2023
13F
Cypress Capital Management LLC (WY)
13F
Company
0%
100
$260 30 Jun 2023
13F
WOLFF WIESE MAGANA LLC
13F
Company
0%
31
$81 30 Jun 2023
13F
1832 Asset Management L.P.
13F
Company
0%
5
$13 30 Jun 2023
13F

Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q3 2023

As of 30 Sep 2023, ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,216,229 shares. The largest 10 holders included Anson Funds Management LP, MILLENNIUM MANAGEMENT LLC, INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, MORGAN STANLEY, CIBC WORLD MARKET INC., Royal Bank of Canada, GEODE CAPITAL MANAGEMENT, LLC, Long Focus Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, and BANK OF MONTREAL /CAN/. This page lists 32 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
28
Q3 2023 holders
32
Holder diff
4
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .